High-yield points
- NCC is the most common parasitic CNS disease :
- parenchymal disease: seizures;
- extraparenchymal disease: hydrocephalus.
- Intraventricular NCC:
- endoscopic cyst removal plus ETV is the gold standard;
- about 80% resolve, and shunt-first management does worse ;
- complete removal in 88%, with only 10% needing a shunt .
- Find the cysts: 3D T2 (SPACE) MRI for membranes; leg X-rays show calcified cysticerci (94%) .
- Single parenchymal cyst: albendazole helps (RR 0.61 for seizure recurrence) . Calcified cysts don't need it .
- Hydatid cyst: a large non-enhancing cyst without edema. Remove intact (Dowling hydrostatic technique); rupture can be fatal .
- Child from an endemic area with transverse myelitis: think schistosomiasis. It is very treatable .
Landmark papers
- IDSA/ASTMH neurocysticercosis guidelines (White et al., Clin Infect Dis 2018): the reference standard for treatment by cyst location and stage .
- Cochrane anthelmintics review (Monk et al., 2021): albendazole reduces seizure recurrence for a single parenchymal cyst (RR 0.61), with uncertain effects for multiple cysts .
Parasitic CNS infections are common in endemic regions and increasingly seen elsewhere through migration and travel. For the neurosurgeon, three matter most:
- neurocysticercosis (NCC), the most common parasitic disease of the CNS, where the surgical problems are intraventricular cysts and hydrocephalus ;
- hydatid (echinococcal) cysts: large cysts that must be removed intact ;
- spinal schistosomiasis: a treatable cause of myelopathy in children from endemic areas .
Neurocysticercosis
- Cause: the larval stage of the pork tapeworm Taenia solium.
- Forms:
- parenchymal (cysts in all stages: vesicular, colloidal, granular, calcified), presenting with seizures;
- extraparenchymal: intraventricular or subarachnoid (racemose), presenting with hydrocephalus and raised ICP (see caveats).
- Guidelines: the 2017 IDSA/ASTMH guidelines cover diagnosis and treatment by form . The specific recommendations are summarized in caveats.
Parenchymal disease: antiparasitic drugs
- Cochrane review (16 trials, mostly albendazole vs none) :
- single cyst (most participants children, nonviable parenchymal cysts):
- albendazole probably reduces seizure recurrence (RR 0.61).
- multiple cysts: very uncertain, with the direction of effect toward harm (RR 2.05).
- all participants (13 trials): albendazole slightly improves radiological clearance (RR 1.22).
- Corticosteroids are given with antiparasitic drugs to limit inflammation as cysts die, and calcified lesions don't need antiparasitic drugs (see caveats).
Extraparenchymal disease: the neurosurgical problem
- Hydrocephalus is the main neurosurgical challenge (review) :
- about 80% complete resolution of hydrocephalus after a first surgical attempt plus medication;
- endoscopic cyst removal with third ventriculostomy was the most common approach and is considered the gold standard;
- patients first managed with shunts did worse, with more complications.
- Endoscopic series (51 patients, mean follow-up 98 months) :
- complete cyst removal in 88.2%;
- recurrence 2.0%;
- only 9.8% needed a VP shunt;
- postoperative infection in 3.9%, with no new deficits.
- Imaging: high-resolution 3D T2 (SPACE) MRI showed cyst membranes in every case. Plain leg radiographs found muscle calcifications in 94.1%, a useful diagnostic clue.
- Fourth-ventricle cysts: can be removed endoscopically or by open approach, such as a telovelar approach (see caveats).
- Racemose subarachnoid NCC:
- basal cisterns, chronic arachnoiditis;
- prolonged antiparasitic and anti-inflammatory therapy;
- shunts often fail from cyst debris and inflammation (see caveats).
Hydatid (echinococcal) cysts
- Cause: larval Echinococcus granulosus, from contact with dogs in sheep-raising regions.
- Presentation (30 children) :
- headache and vomiting (raised ICP) were commonest;
- neurological deficits from mass effect in half;
- seizures were rare.
- Young children may present with an enlarging head alone .
- Imaging:
- a large, round, thin-walled cyst with CSF-like contents;
- no enhancement or edema, unless complicated or infected .
- Enhancement of the pericyst suggests an infected or complicated cyst .
- Surgery: remove it intact.
- Intact removal in 29 of 30; the one cyst that ruptured during dissection resulted in death .
- Dowling technique : hydrostatic dissection with saline irrigated between the cyst and brain, plus head rotation so gravity delivers the cyst. All 9 patients were recurrence-free at a median of 18 months.
- Rupture risks:
- anaphylaxis;
- recurrence from spilled scolices;
- chemical meningitis.
- Protect the field with saline-soaked cottonoids (see caveats).
- Medical therapy after surgery for multiple or deep-seated cysts , usually albendazole (see caveats).
Spinal schistosomiasis (neuroschistosomiasis)
- Cause: Schistosoma mansoni (and others), from freshwater contact in endemic areas.
- Where: the lower thoracic cord and the lumbar and lumbosacral region . It presents as myelopathy or a conus–cauda equina syndrome, and can mimic a tumor (see caveats).
- Diagnosis: consider it in any child from an endemic region with transverse myelitis .
- Treatment: simple and effective (praziquantel and steroids), with full recovery when diagnosed early .
- Surgery is reserved for diagnostic doubt (a mass mimicking tumor) or cord compression (see caveats).
Other parasites (brief)
- Toxoplasmosis: ring-enhancing lesions in immunocompromised children, and congenital hydrocephalus with calcifications.
- Cerebral malaria: raised ICP, managed medically.
- Paragonimiasis and sparganosis: migrating granulomas. Surgery is sometimes needed for removal.
- (See caveats.)
Related topics
- Endoscopic Third Ventriculostomy (ETV): the endoscopic technique used with cyst removal.
- Management of Hydrocephalus in Bacterial and Viral Meningitis: postinfectious hydrocephalus.
- Brain Abscess in Children: the differential for ring-enhancing lesions.
- Arachnoid Cysts in Children: the differential for a large non-enhancing cyst.
- Central Nervous System Tuberculosis: Neurosurgical Implications: another granulomatous infection.
References
- Yamaki VN, Telles JPM, Yamashita RHG, et al. Neurocysticercosis: challenges in pediatric neurosurgery practice. Childs Nerv Syst 2023;39(3):743–750. doi:10.1007/s00381-022-05784-1. PMID 36689000. verified
- Duishanbai S, Jiafu D, Guo H, et al. Intracranial hydatid cyst in children: report of 30 cases. Childs Nerv Syst 2010;26(6):821–827. doi:10.1007/s00381-009-1008-2. PMID 20013283. verified
- Mohindra S, Savardekar A, Gupta R, et al. Varied types of intracranial hydatid cysts: radiological features and management techniques. Acta Neurochir (Wien) 2012;154(1):165–172. doi:10.1007/s00701-011-1181-4. PMID 21969224. verified
- Dastoli PA, da Costa MDS, Nicácio JM, et al. Mansonic neuroschistosomiasis in the childhood: an undiagnosed pathology? Childs Nerv Syst 2023;39(2):481–489. doi:10.1007/s00381-022-05696-0. PMID 36258049. verified
- White AC Jr, Coyle CM, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 2018;66(8):e49–e75. doi:10.1093/cid/cix1084. PMID 29481580. verified
- Monk EJM, Abba K, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 2021;6(6):CD000215. doi:10.1002/14651858.CD000215.pub5. PMID 34060667. verified
- Xu X, Zhang J, Guo Z, et al. Endoscopic management of intraventricular and subarachnoid neurocysticercosis: technical workflow and clinical outcome. Neurosurg Focus 2025;59(5):E5. doi:10.3171/2025.8.FOCUS25686. PMID 41175400. verified
Verification (2026-11-18):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.
- Reference 5 has no PubMed abstract and is cited as the guideline itself.
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- the NCC forms and stages;
- the IDSA/ASTMH guideline's specific recommendations (steroids with antiparasitics, no antiparasitics for calcified cysts, endoscopic removal of ventricular cysts), which should be checked against reference 5's full text;
- the fourth-ventricle approach options;
- racemose disease management and shunt failure;
- hydatid rupture risks and field protection;
- schistosomiasis drug names and surgical indications;
- the "other parasites" list;
- hydatid exposure through dogs in sheep-raising regions, schistosomiasis through freshwater contact, and albendazole as the usual drug after hydatid surgery;
- the schistosomiasis presentation as conus–cauda equina syndrome and tumor mimicry.
- Reference 7 is a mostly adult series (mean age 43).
- Reference 3 includes adults.
- The figure is an original schematic.